GlassScriptPhysician profile
Darin D Tessier
NPI 1164603866
$5,271.15
in general payments reported to CMS, 2019-2025
20 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $375 · 2021: $37.85 · 2022: $485 · 2023: $1,291 · 2024: $1,904 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,629 · Food and Beverage: $999 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,628.80 |
| Food and Beverage | $999.44 |
| Travel and Lodging | $907.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $1,762.07 | 2022-2024 | |
| Medinc of Texas | $955.50 | 2019-2025 | |
| Linvatec Corporation | $907.30 | 2023 | Biobrace 23mm |
| Arthrosurface Incorporated | $291.02 | 2020-2025 | Revomotion, Ovomotion |
| Anika Therapeutics, INC. | $197.82 | 2022-2024 | Revomotion |
| Flower Orthopedics Coporation | $192.83 | 2023 | |
| Stryker Corporation | $188.80 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $188.02 | 2022 | |
| International Life Sciences | $159.25 | 2020 | |
| Imbed Biosciences INC. | $88.57 | 2022 | |
| Sanara Medtech INC. | $76.43 | 2021-2022 | |
| Restor3d, INC. | $48.27 | 2025 | |
| Medacta USA, INC. | $47.44 | 2025 | Mpact |
| Vertex Pharmaceuticals Incorporated | $41.47 | 2025 | |
| Arcuro Medical INC | $40.69 | 2024 | Superball |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $24.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.63 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $15.80 | 2023 | Iovera, Zilretta, Exparel |
| Alafair Biosciences, INC. | $15.00 | 2023 | Versawrap |
| Pacira Therapeutics, INC. | $12.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Tessier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.